Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
331
-
Total 13F shares, excl. options
-
33.6M
-
Shares change
-
+290K
-
Total reported value, excl. options
-
$5.06B
-
Value change
-
+$90.8M
-
Put/Call ratio
-
0.39
-
Number of buys
-
194
-
Number of sells
-
-136
-
Price
-
$150.62
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2024
377 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2024.
TransMedics Group, Inc. - Common Stock (TMDX) has 331 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.6M shares
of 33.9M outstanding shares and own 98.92% of the company stock.
Largest 10 shareholders include FMR LLC (4.49M shares), BlackRock Inc. (2.65M shares), VANGUARD GROUP INC (2.53M shares), Driehaus Capital Management LLC (1.49M shares), Invesco Ltd. (1.36M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.15M shares), ArrowMark Colorado Holdings LLC (1.14M shares), MACQUARIE GROUP LTD (956K shares), STATE STREET CORP (783K shares), and GEODE CAPITAL MANAGEMENT, LLC (754K shares).
This table shows the top 331 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.